EBS - Better Coronavirus Stock: Emergent BioSolutions vs. Gilead Sciences
To be sure, no drug has yet been proven to be effective in treating novel coronavirus disease COVID-19. Any claims that you might read online about one drug or another being a silver bullet for the disease are premature at best. However, what is true right now is that several companies are developing therapies that hold the potential to be effective at treating COVID-19.
Two of the players at the forefront of these efforts are Emergent BioSolutions (NYSE: EBS) and Gilead Sciences (NASDAQ: GILD). Both biotech stocks have been winners so far in 2020 while most stocks have plunged. Which is the better pick for long-term investors?
Image source: Getty Images.